CSIMarket



Worst Performing Stocks In Medical Laboratories Industry During The Previous 90 Days



 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 
 

Shares improved by 8.98% on average, in Medical Laboratories Industry during the previous 90 days.

Here are the Worst performing stocks in Medical Laboratories Industry.




RNLX

$0.3

$-0.5300 -63.86%
Last 90 Days


RNLX

$0.3

$-0.5300 -63.86%



Renalytix Plc

Renalytix Plc shares dropped -63.86% during the previous 90 days.


Renalytix Plc is a biotechnology company that focuses on developing and commercializing diagnostic tests for kidney disease. Their business model centers around using advanced biomarkers and artificial intelligence to enhance the accuracy and speed of identifying kidney disease, ultimately improving patient outcomes. Renalytix aims to provide healthcare professionals with innovative tools that enable personalized treatments and reduce the overall burden of kidney disease on individuals and healthcare systems.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 28.430 mill. $ 6.832 mill. $ -101.037 mill. 95 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 28.430 mill.


$ 6.832 mill.


$ -101.037 mill.

Employees Shares Outstanding P/E

-


95 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NOTV

$2.06

$-3.3600 -61.99%
Last 90 Days


NOTV

$2.06

$-3.3600 -61.99%



Inotiv Inc

Inotiv Inc stock went down -61.99% during the previous 90 days.


Inotiv Inc is a contract research organization (CRO) that provides preclinical and nonclinical research services to the pharmaceutical, biotechnology, and medical device companies. The company offers a range of services including drug discovery, safety assessment, toxicology testing, and analytical services. By assisting clients with their research and development needs, Inotiv aims to contribute to the advancement of medicine and the development of new treatment options.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 53.212 mill. $ 552.744 mill. $ -71.368 mill. 26 mill. - Y/Y -21.41 %
Market Cap. Revenues TTM Net Income TTM

$ 53.212 mill.


$ 552.744 mill.


$ -71.368 mill.

Employees Shares Outstanding P/E

-


26 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -21.41 %


MRQ Y/Y - %



OPGN

$3.01

$-2.9890 -49.82%
Last 90 Days


OPGN

$3.01

$-2.9890 -49.82%



Opgen Inc

Opgen Inc shares declined -49.82% during the previous 90 days.


OpGen Inc*s business model revolves around providing molecular diagnostic solutions and informatics services to combat global healthcare challenges, particularly in the field of infectious diseases. They develop innovative technologies that assist healthcare professionals in identifying, treating, and preventing the spread of infectious pathogens.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.008 mill. $ 2.673 mill. $ -26.659 mill. 1 mill. - Y/Y -81.59 %
Market Cap. Revenues TTM Net Income TTM

$ 4.008 mill.


$ 2.673 mill.


$ -26.659 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -81.59 %


MRQ Y/Y - %



NRC

$24.31

$-9.0100 -27.04%
Last 90 Days


NRC

$24.31

$-9.0100 -27.04%



National Research Corporation

National Research Corporation stock declined -27.04% during the previous 90 days.


National Research Corporation (NRC) operates as a healthcare research and performance measurement firm, providing insights and data-driven solutions. They collect, analyze, and interpret patient and healthcare provider feedback to assist organizations in improving their overall quality of care. NRC*s business model focuses on selling research products, licensing data services, and providing consulting solutions to healthcare organizations seeking to enhance patient experiences and outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 582.541 mill. $ 147.420 mill. $ 30.366 mill. 24 mill. 19.57 Y/Y -3.18 %
Market Cap. Revenues TTM Net Income TTM

$ 582.541 mill.


$ 147.420 mill.


$ 30.366 mill.

Employees Shares Outstanding P/E

-


24 mill.


19.57

Revenue Growth Income Growth

MRQ Y/Y -3.18 %


MRQ Y/Y -8.69 %



GPFT

$0.0011

$-0.0004 -26.67%
Last 90 Days


GPFT

$0.0011

$-0.0004 -26.67%



Grapefruit Usa Inc

Grapefruit Usa Inc stock dropped -26.67% during the previous 90 days.


Grapefruit USA Inc operates as a fully licensed cannabis distribution and manufacturing company. They focus on producing premium, high-quality cannabis products and efficiently distributing them to licensed retailers in the United States.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.631 mill. $ 0.035 mill. $ -4.367 mill. 574 mill. - Y/Y -98.07 %
Market Cap. Revenues TTM Net Income TTM

$ 0.631 mill.


$ 0.035 mill.


$ -4.367 mill.

Employees Shares Outstanding P/E

-


574 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -98.07 %


MRQ Y/Y - %



FTRE

$26.81

$-9.7000 -26.57%
Last 90 Days


FTRE

$26.81

$-9.7000 -26.57%



Fortrea Holdings Inc

Fortrea Holdings Inc shares declined -26.57% during the previous 90 days.


Fortrea Holdings Inc is a company that operates through its subsidiaries in the business of software and technology services, providing innovative solutions and products to its clients. Its business model focuses on developing and delivering custom software applications, digital platforms, and consulting services to cater to the specific needs of various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,396.292 mill. $ 3,771.100 mill. $ -104.400 mill. 89 mill. - Y/Y -78.70 %
Market Cap. Revenues TTM Net Income TTM

$ 2,396.292 mill.


$ 3,771.100 mill.


$ -104.400 mill.

Employees Shares Outstanding P/E

-


89 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -78.70 %


MRQ Y/Y - %



EXAS

$48.165

$-15.0550 -23.81%
Last 90 Days


EXAS

$48.165

$-15.0550 -23.81%



Exact Sciences Corporation

Exact Sciences Corporation stock went down -23.81% during the previous 90 days.


Exact Sciences Corporation is a medical diagnostics company that specializes in early cancer detection. Their business model involves developing and commercializing non-invasive, DNA-based tests for the detection of colorectal cancer, as well as other cancers and diseases. By leveraging advanced technology and partnerships with healthcare providers, Exact Sciences aims to improve patient outcomes through early detection and intervention.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 8,782.888 mill. $ 2,573.276 mill. $ -240.226 mill. 182 mill. - Y/Y 6.77 %
Market Cap. Revenues TTM Net Income TTM

$ 8,782.888 mill.


$ 2,573.276 mill.


$ -240.226 mill.

Employees Shares Outstanding P/E

5,361


182 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 6.77 %


MRQ Y/Y - %



ABSI

$4.1

$-1.1900 -22.50%
Last 90 Days


ABSI

$4.1

$-1.1900 -22.50%



Absci Corp

Absci Corp shares dropped -22.50% during the previous 90 days.


Absci Corp*s business model focuses on driving innovation in drug discovery and development through their integrated synthetic biology platform. They offer a comprehensive suite of services that enable clients to rapidly and efficiently discover, develop, and manufacture new biotherapeutics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 407.513 mill. $ 5.347 mill. $ -109.186 mill. 99 mill. - Y/Y -29.24 %
Market Cap. Revenues TTM Net Income TTM

$ 407.513 mill.


$ 5.347 mill.


$ -109.186 mill.

Employees Shares Outstanding P/E

-


99 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -29.24 %


MRQ Y/Y - %



BGLC

$0.4954

$-0.1379 -21.77%
Last 90 Days


BGLC

$0.4954

$-0.1379 -21.77%



Bionexus Gene Lab Corp

Bionexus Gene Lab Corp shares declined -21.77% during the previous 90 days.


Bionexus Gene Lab Corp operates on a business model focused on genetic research and analysis. They provide services such as genetic testing, gene sequencing, and genetic counseling to individuals and institutions. By utilizing advanced technology and expertise, they aim to assist their clients in understanding genetic information for medical purposes and improved decision-making.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 8.753 mill. $ 9.775 mill. $ -2.664 mill. 18 mill. - Y/Y 0.20 %
Market Cap. Revenues TTM Net Income TTM

$ 8.753 mill.


$ 9.775 mill.


$ -2.664 mill.

Employees Shares Outstanding P/E

-


18 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 0.20 %


MRQ Y/Y - %



SERA

$7.62

$-2.0600 -21.28%
Last 90 Days


SERA

$7.62

$-2.0600 -21.28%



Sera Prognostics Inc

Sera Prognostics Inc stock dropped -21.28% during the previous 90 days.


Sera Prognostics Inc has a business model that focuses on developing and commercializing innovative diagnostic tests for predicting pregnancy complications.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 245.517 mill. $ - mill. $ -33.774 mill. 32 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 245.517 mill.


$ - mill.


$ -33.774 mill.

Employees Shares Outstanding P/E

-


32 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NNOX

$7.71

$-1.6400 -17.54%
Last 90 Days


NNOX

$7.71

$-1.6400 -17.54%



Nano x Imaging Ltd

Nano X Imaging Ltd shares went down -17.54% during the previous 90 days.


Nano X Imaging Ltd is a medical imaging technology company that aims to revolutionize the field by developing and commercializing a novel digital X-ray system. Their business model involves building partnerships with healthcare providers, imaging equipment manufacturers, and distributors to bring their innovative technology to market, providing cost-effective and accessible diagnostic solutions globally. By delivering high-quality imaging at a fraction of the cost of traditional systems, Nano X Imaging aims to improve healthcare outcomes and increase patient access to effective diagnostics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 434.597 mill. $ 9.905 mill. $ -60.776 mill. 56 mill. - Y/Y 15.47 %
Market Cap. Revenues TTM Net Income TTM

$ 434.597 mill.


$ 9.905 mill.


$ -60.776 mill.

Employees Shares Outstanding P/E

-


56 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 15.47 %


MRQ Y/Y - %



HALB

$0.0075

$-0.0014 -15.73%
Last 90 Days


HALB

$0.0075

$-0.0014 -15.73%



Halberd Corporation

Halberd Corporation shares declined -15.73% during the previous 90 days.


Halberd Corporation*s business model focuses on providing a range of products or services to meet specific industries* needs, with a targeted approach and a customer-centric approach.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3.847 mill. $ 0.001 mill. $ -0.297 mill. 513 mill. - Y/Y -99.99 %
Market Cap. Revenues TTM Net Income TTM

$ 3.847 mill.


$ 0.001 mill.


$ -0.297 mill.

Employees Shares Outstanding P/E

-


513 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -99.99 %


MRQ Y/Y - %



FOXO

$0.23

$-0.0406 -15.00%
Last 90 Days


FOXO

$0.23

$-0.0406 -15.00%



Foxo Technologies Inc

Foxo Technologies Inc stock went down -15.00% during the previous 90 days.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.122 mill. $ 0.546 mill. $ -109.518 mill. 5 mill. - Y/Y -28.57 %
Market Cap. Revenues TTM Net Income TTM

$ 1.122 mill.


$ 0.546 mill.


$ -109.518 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -28.57 %


MRQ Y/Y - %



LWLG

$3.53

$-0.5600 -13.69%
Last 90 Days


LWLG

$3.53

$-0.5600 -13.69%



Lightwave Logic Inc

Lightwave Logic Inc stock went down -13.69% during the previous 90 days.


Lightwave Logic Inc*s business model is focused on developing and commercializing advanced photonic devices and technologies for various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 419.896 mill. $ 0.030 mill. $ -21.778 mill. 119 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 419.896 mill.


$ 0.030 mill.


$ -21.778 mill.

Employees Shares Outstanding P/E

10


119 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



BIAF

$2.53

$-0.3800 -13.06%
Last 90 Days


BIAF

$2.53

$-0.3800 -13.06%



Bioaffinity Technologies Inc

Bioaffinity Technologies Inc stock declined -13.06% during the previous 90 days.


Bioaffinity Technologies Inc is a biotechnology company specializing in developing and commercializing diagnostics for various medical conditions. They utilize their patented platform technology, Affinity?, which enables the detection of cancer and other diseases at an early stage through the use of biomarkers. The company focuses on licensing their technology and partnering with diagnostic companies, aiming to provide accurate, non-invasive, and cost-effective diagnostic solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 25.086 mill. $ 4.938 mill. $ -8.366 mill. 10 mill. - Y/Y 261,180.24 %
Market Cap. Revenues TTM Net Income TTM

$ 25.086 mill.


$ 4.938 mill.


$ -8.366 mill.

Employees Shares Outstanding P/E

-


10 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 261,180.24 %


MRQ Y/Y - %



BNR

$7.07

$-0.9300 -11.63%
Last 90 Days


BNR

$7.07

$-0.9300 -11.63%



Burning Rock Biotech Limited

Burning Rock Biotech Limited stock dropped -11.63% during the previous 90 days.


Burning Rock Biotech Limited is a company that specializes in molecular diagnostics for cancer.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ - mill. $ 75.696 mill. $ -92.070 mill. - mill. - Y/Y -7.31 %
Market Cap. Revenues TTM Net Income TTM

$ - mill.


$ 75.696 mill.


$ -92.070 mill.

Employees Shares Outstanding P/E

-


- mill.


-

Revenue Growth Income Growth

MRQ Y/Y -7.31 %


MRQ Y/Y - %



CHEK

$1.98

$-0.2000 -9.17%
Last 90 Days


CHEK

$1.98

$-0.2000 -9.17%



Check cap Ltd

Check Cap Ltd shares declined -9.17% during the previous 90 days.


Check Cap Ltd is a medical technology company that develops and commercializes an ingestible imaging capsule that allows for the detection and monitoring of colorectal polyps. Their business model revolves around manufacturing and selling this capsule device while also providing associated services and support to healthcare professionals and patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 11.580 mill. $ - mill. $ 17.568 mill. 6 mill. 0.66 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 11.580 mill.


$ - mill.


$ 17.568 mill.

Employees Shares Outstanding P/E

-


6 mill.


0.66

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y -8.06 %



PMD

$2.33

$-0.2100 -8.27%
Last 90 Days


PMD

$2.33

$-0.2100 -8.27%



Psychemedics Corporation

Psychemedics Corporation shares went down -8.27% during the previous 90 days.


Psychemedics Corp*s business model is focused on providing hair drug testing services to corporate clients, law enforcement agencies, and individuals. They collect hair samples, conduct extensive laboratory analysis, and deliver accurate and confidential drug test results to their customers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 13.528 mill. $ 20.676 mill. $ -4.458 mill. 6 mill. - Y/Y -12.58 %
Market Cap. Revenues TTM Net Income TTM

$ 13.528 mill.


$ 20.676 mill.


$ -4.458 mill.

Employees Shares Outstanding P/E

-


6 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -12.58 %


MRQ Y/Y - %



GEHC

$81.23

$-3.9600 -4.65%
Last 90 Days


GEHC

$81.23

$-3.9600 -4.65%



Ge Healthcare Technologies Inc

Ge Healthcare Technologies Inc stock declined -4.65% during the previous 90 days.


GE Healthcare Technologies Inc*s business model is focused on providing innovative medical devices, healthcare information technology, and healthcare services to improve patient care and outcomes. The company offers a wide range of products and solutions in areas such as medical imaging, patient monitoring, diagnostics, and healthcare IT. They also collaborate with healthcare providers and partners to offer integrated solutions and support throughout the entire healthcare ecosystem.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 37,284.570 mill. $ 16,328.000 mill. $ 1,619.000 mill. 459 mill. 23.77 Y/Y -1.50 %
Market Cap. Revenues TTM Net Income TTM

$ 37,284.570 mill.


$ 16,328.000 mill.


$ 1,619.000 mill.

Employees Shares Outstanding P/E

-


459 mill.


23.77

Revenue Growth Income Growth

MRQ Y/Y -1.50 %


MRQ Y/Y 1.31 %



LUNA

$2.67

$-0.0900 -3.26%
Last 90 Days


LUNA

$2.67

$-0.0900 -3.26%



Luna Innovations Inc

Luna Innovations Inc shares went down -3.26% during the previous 90 days.


Luna Innovations Inc*s business model involves providing advanced technology solutions and services to various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 94.034 mill. $ 113.692 mill. $ -1.781 mill. 35 mill. - Y/Y 17.07 %
Market Cap. Revenues TTM Net Income TTM

$ 94.034 mill.


$ 113.692 mill.


$ -1.781 mill.

Employees Shares Outstanding P/E

236


35 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 17.07 %


MRQ Y/Y - %



CRL

$227.62

$-2.4700 -1.07%
Last 90 Days


CRL

$227.62

$-2.4700 -1.07%



Charles River Laboratories International inc

Charles River Laboratories International Inc shares dropped -1.07% during the previous 90 days.


Charles River Laboratories International Inc is a contract research organization (CRO) that provides essential services and support to the pharmaceutical, biotech, and medical device industries. They offer a wide range of research models, drug discovery and development services, safety assessments, and laboratory animal medicine to assist in the preclinical and clinical stages of drug development.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 11,800.276 mill. $ 4,111.596 mill. $ 450.898 mill. 52 mill. 26.77 Y/Y -1.73 %
Market Cap. Revenues TTM Net Income TTM

$ 11,800.276 mill.


$ 4,111.596 mill.


$ 450.898 mill.

Employees Shares Outstanding P/E

20,000


52 mill.


26.77

Revenue Growth Income Growth

MRQ Y/Y -1.73 %


MRQ Y/Y -28.35 %



VRDN

$14.98

$-0.1000 -0.66%
Last 90 Days


VRDN

$14.98

$-0.1000 -0.66%



Viridian Therapeutics Inc

Viridian Therapeutics Inc stock went down -0.66% during the previous 90 days.


Viridian Therapeutics Inc is a biotechnology company that focuses on developing novel therapeutics to treat various diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 915.264 mill. $ 0.288 mill. $ -218.125 mill. 61 mill. - Y/Y -26.53 %
Market Cap. Revenues TTM Net Income TTM

$ 915.264 mill.


$ 0.288 mill.


$ -218.125 mill.

Employees Shares Outstanding P/E

-


61 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -26.53 %


MRQ Y/Y - %



OABI

$4.81

$0.0300 0.63%
Last 90 Days


OABI

$4.81

$0.0300 0.63%



Omniab Inc

Omniab Inc shares increased 0.63% during the previous 90 days.


Omniab Inc is a technology company that operates on a B2B (business-to-business) model, offering a range of software solutions and services. The company focuses on providing customized software applications to help businesses streamline their operations, enhance productivity, and improve efficiency. Omniab Inc also offers consultation services to assist companies in optimizing their IT infrastructure.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 484.632 mill. $ 21.046 mill. $ -63.480 mill. 101 mill. - Y/Y -77.53 %
Market Cap. Revenues TTM Net Income TTM

$ 484.632 mill.


$ 21.046 mill.


$ -63.480 mill.

Employees Shares Outstanding P/E

-


101 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -77.53 %


MRQ Y/Y - %



ENZ

$1.17

$0.0200 1.74%
Last 90 Days


ENZ

$1.17

$0.0200 1.74%



Enzo Biochem Inc

Enzo Biochem Inc stock went up 1.74% during the previous 90 days.


Enzo Biochem Inc operates as a biotechnology company that specializes in the development and commercialization of innovative diagnostic and research products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 59.690 mill. $ 32.466 mill. $ 32.566 mill. 51 mill. 0.00 Y/Y -47.65 %
Market Cap. Revenues TTM Net Income TTM

$ 59.690 mill.


$ 32.466 mill.


$ 32.566 mill.

Employees Shares Outstanding P/E

412


51 mill.


0.00

Revenue Growth Income Growth

MRQ Y/Y -47.65 %


MRQ Y/Y - %



ACON

$0.3056

$0.0087 2.93%
Last 90 Days


ACON

$0.3056

$0.0087 2.93%



Aclarion Inc

Aclarion Inc shares went up 2.93% during the previous 90 days.


Aclarion Inc is a technology company that operates on a software-as-a-service (SaaS) business model. They provide their customers with cloud-based solutions, enabling them to streamline and automate their business processes efficiently. Aclarion offers a range of customizable software solutions, including data management, project management, and collaboration tools, tailored to meet the specific needs of their clients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.663 mill. $ 0.060 mill. $ -6.127 mill. 5 mill. - Y/Y -60.29 %
Market Cap. Revenues TTM Net Income TTM

$ 1.663 mill.


$ 0.060 mill.


$ -6.127 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -60.29 %


MRQ Y/Y - %



HOLX

$78.38

$3.4600 4.62%
Last 90 Days


HOLX

$78.38

$3.4600 4.62%



Hologic Inc

Hologic Inc shares went up 4.62% during the previous 90 days.


Hologic Inc*s business model revolves around the development, manufacturing, and commercialization of medical technology and diagnostic products, primarily focused on women*s healthcare. They aim to provide innovative solutions for various medical specialties, including breast and skeletal health, gynecological health, and surgical products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 18,620.110 mill. $ 4,046.300 mill. $ 621.900 mill. 238 mill. 29.92 Y/Y -0.85 %
Market Cap. Revenues TTM Net Income TTM

$ 18,620.110 mill.


$ 4,046.300 mill.


$ 621.900 mill.

Employees Shares Outstanding P/E

6,944


238 mill.


29.92

Revenue Growth Income Growth

MRQ Y/Y -0.85 %


MRQ Y/Y -22.24 %



CSTL

$19.9

$1.0600 5.63%
Last 90 Days


CSTL

$19.9

$1.0600 5.63%



Castle Biosciences Inc

Castle Biosciences Inc stock improved 5.63% during the previous 90 days.


Castle Biosciences Inc is a biotechnology company that specializes in the development and commercialization of diagnostic tests for specialized cancers. Their business model revolves around leveraging molecular diagnostic technologies to provide physicians with personalized, actionable information when making treatment decisions for patients with difficult-to-diagnose or higher-risk cancers. By offering these tests, Castle Biosciences aims to improve patient outcomes and contribute to the advancement of precision medicine.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 546.952 mill. $ 250.725 mill. $ -0.132 mill. 27 mill. - Y/Y 73.59 %
Market Cap. Revenues TTM Net Income TTM

$ 546.952 mill.


$ 250.725 mill.


$ -0.132 mill.

Employees Shares Outstanding P/E

200


27 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 73.59 %


MRQ Y/Y - %



LH

$214.34

$14.3700 7.19%
Last 90 Days


LH

$214.34

$14.3700 7.19%



Laboratory Corporation Of America Holdings

Laboratory Corporation Of America Holdings stock improved 7.19% during the previous 90 days.


Laboratory Corporation Of America Holdings operates as a leading healthcare diagnostics company. They offer a range of clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model focuses on providing accurate and timely test results, enabling healthcare professionals to diagnose, treat, and monitor patients effectively.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 18,167.108 mill. $ 11,560.300 mill. $ 434.200 mill. 85 mill. 43.30 Y/Y -15.92 %
Market Cap. Revenues TTM Net Income TTM

$ 18,167.108 mill.


$ 11,560.300 mill.


$ 434.200 mill.

Employees Shares Outstanding P/E

75,500


85 mill.


43.30

Revenue Growth Income Growth

MRQ Y/Y -15.92 %


MRQ Y/Y 7.03 %



CELC

$18.27

$1.2600 7.41%
Last 90 Days


CELC

$18.27

$1.2600 7.41%



Celcuity Inc

Celcuity Inc stock improved 7.41% during the previous 90 days.


Celcuity Inc is a biotechnology company that develops and commercializes diagnostic tests designed to classify patients* specific cancer subtypes. These tests help physicians select the most appropriate targeted therapies for their patients, ultimately improving treatment outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 614.092 mill. $ - mill. $ -74.498 mill. 34 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 614.092 mill.


$ - mill.


$ -74.498 mill.

Employees Shares Outstanding P/E

-


34 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



IQV

$245.23

$17.9800 7.91%
Last 90 Days


IQV

$245.23

$17.9800 7.91%



Iqvia Holdings Inc

Iqvia Holdings Inc shares went up 7.91% during the previous 90 days.


IQVIA Holdings Inc is a multinational company that operates in the healthcare industry. Its business model revolves around providing advanced analytics, technology solutions, and clinical research services to help clients make informed decisions, optimize their operations, and accelerate drug development. By leveraging its vast data resources and expertise, IQVIA aims to support healthcare professionals in improving patient outcomes and driving innovation in the industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 45,195.889 mill. $ 15,069.000 mill. $ 1,357.000 mill. 184 mill. 33.34 Y/Y 2.33 %
Market Cap. Revenues TTM Net Income TTM

$ 45,195.889 mill.


$ 15,069.000 mill.


$ 1,357.000 mill.

Employees Shares Outstanding P/E

79,000


184 mill.


33.34

Revenue Growth Income Growth

MRQ Y/Y 2.33 %


MRQ Y/Y -0.35 %



CNTG

$0.5194

$0.0394 8.21%
Last 90 Days


CNTG

$0.5194

$0.0394 8.21%



Centogene N v

Centogene N V shares increased 8.21% during the previous 90 days.


Centogene N v operates in the field of rare genetic diseases, offering genetic testing and diagnostics services to patients, healthcare providers, and pharmaceutical companies. Their business model involves leveraging their extensive knowledge and expertise in genetic analysis and interpreting data to provide accurate diagnoses and personalized treatment options for individuals with rare genetic disorders. Additionally, they collaborate with pharmaceutical companies to assist in drug development and clinical trials for rare diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 14.532 mill. $ 54.319 mill. $ -39.796 mill. 28 mill. - Y/Y 2.16 %
Market Cap. Revenues TTM Net Income TTM

$ 14.532 mill.


$ 54.319 mill.


$ -39.796 mill.

Employees Shares Outstanding P/E

500


28 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 2.16 %


MRQ Y/Y - %



AMS

$3.25

$0.2600 8.70%
Last 90 Days


AMS

$3.25

$0.2600 8.70%



American Shared Hospital Services

American Shared Hospital Services stock increased 8.70% during the previous 90 days.


American Shared Hospital Services (ASHS) operates a unique business model by providing state-of-the-art medical equipment on a shared basis to hospitals and medical centers across the United States. They establish partnerships with healthcare providers, offering the latest technology for radiation therapy, radiosurgery, and nuclear medicine without the need for significant capital investments. By leveraging their expertise and established relationships in the healthcare industry, ASHS delivers cost-effective solutions that benefit both patients and healthcare facilities alike.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 21.372 mill. $ 20.562 mill. $ 0.230 mill. 7 mill. 38.72 Y/Y 4.43 %
Market Cap. Revenues TTM Net Income TTM

$ 21.372 mill.


$ 20.562 mill.


$ 0.230 mill.

Employees Shares Outstanding P/E

-


7 mill.


38.72

Revenue Growth Income Growth

MRQ Y/Y 4.43 %


MRQ Y/Y -35.00 %



FLGT

$22.34

$2.2500 11.20%
Last 90 Days


FLGT

$22.34

$2.2500 11.20%



Fulgent Genetics Inc

Fulgent Genetics Inc shares increased 11.20% during the previous 90 days.


Fulgent Genetics Inc is a genetic testing company that offers comprehensive, flexible, and affordable genetic testing solutions for various applications, including clinical diagnostics, carrier screening, and genetic research.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 670.490 mill. $ 285.288 mill. $ -64.981 mill. 30 mill. - Y/Y -20.64 %
Market Cap. Revenues TTM Net Income TTM

$ 670.490 mill.


$ 285.288 mill.


$ -64.981 mill.

Employees Shares Outstanding P/E

284


30 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -20.64 %


MRQ Y/Y - %



MEDP

$437.18

$54.7400 14.31%
Last 90 Days


MEDP

$437.18

$54.7400 14.31%



Medpace Holdings Inc

Medpace Holdings Inc stock increased 14.31% during the previous 90 days.


Medpace Holdings Inc is a contract research organization (CRO) that provides various services in the clinical research and development of drugs and medical devices.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 13,990.197 mill. $ 1,962.812 mill. $ 312.507 mill. 32 mill. 44.41 Y/Y 17.73 %
Market Cap. Revenues TTM Net Income TTM

$ 13,990.197 mill.


$ 1,962.812 mill.


$ 312.507 mill.

Employees Shares Outstanding P/E

3,900


32 mill.


44.41

Revenue Growth Income Growth

MRQ Y/Y 17.73 %


MRQ Y/Y 40.74 %



MXCT

$4.51

$0.5700 14.47%
Last 90 Days


MXCT

$4.51

$0.5700 14.47%



Maxcyte inc

Maxcyte Inc shares improved 14.47% during the previous 90 days.


Maxcyte Inc*s business model revolves around providing cell engineering and flow electroporation technology to facilitate drug discovery, development, and manufacturing processes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 469.445 mill. $ 44.054 mill. $ -36.567 mill. 104 mill. - Y/Y 32.25 %
Market Cap. Revenues TTM Net Income TTM

$ 469.445 mill.


$ 44.054 mill.


$ -36.567 mill.

Employees Shares Outstanding P/E

-


104 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 32.25 %


MRQ Y/Y - %



GNOM

$11.46

$1.5719 15.90%
Last 90 Days


GNOM

$11.46

$1.5719 15.90%



Complete Genomics Inc

Complete Genomics Inc stock improved 15.90% during the previous 90 days.


Complete Genomics Inc operates in the field of genetic sequencing, offering end-to-end solutions for large-scale genomic research. They provide comprehensive DNA sequencing services, including sample preparation, sequencing, data analysis, and consulting, primarily catering to research institutions, pharmaceutical companies, and academic organizations.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 393.476 mill. $ 19.877 mill. $ -57.048 mill. 34 mill. - Y/Y -62.39 %
Market Cap. Revenues TTM Net Income TTM

$ 393.476 mill.


$ 19.877 mill.


$ -57.048 mill.

Employees Shares Outstanding P/E

-


34 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -62.39 %


MRQ Y/Y - %



DGX

$147.35

$20.3700 16.04%
Last 90 Days


DGX

$147.35

$20.3700 16.04%



Quest Diagnostics Inc

Quest Diagnostics Inc shares increased 16.04% during the previous 90 days.


Quest Diagnostics Inc operates as a provider of clinical laboratory and diagnostic information services, serving patients, physicians, hospitals, and pharmaceutical companies. The company generates revenue by offering a range of diagnostic testing services, including laboratory analysis, test development, and specialized diagnostics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 16,503.200 mill. $ 9,287.000 mill. $ 899.000 mill. 112 mill. 19.88 Y/Y 1.50 %
Market Cap. Revenues TTM Net Income TTM

$ 16,503.200 mill.


$ 9,287.000 mill.


$ 899.000 mill.

Employees Shares Outstanding P/E

49,000


112 mill.


19.88

Revenue Growth Income Growth

MRQ Y/Y 1.50 %


MRQ Y/Y -4.15 %



ICLR

$339.93

$47.9100 16.41%
Last 90 Days


ICLR

$339.93

$47.9100 16.41%



Icon Plc

Icon Plc stock went up 16.41% during the previous 90 days.


Icon Plc is a leading provider of clinical research services, specializing in the design and management of clinical trials for pharmaceutical and biotechnology companies. Their business model focuses on offering a comprehensive range of services, including study design, data management, regulatory support, and statistical analysis, to support the development of new drugs and medical devices. Icon Plc*s success lies in its ability to provide customized solutions to its clients, efficiently navigate the regulatory landscape, and consistently deliver high-quality and timely results.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 28,118.207 mill. $ 8,120.176 mill. $ 1,236.802 mill. 83 mill. 45.94 Y/Y 4.89 %
Market Cap. Revenues TTM Net Income TTM

$ 28,118.207 mill.


$ 8,120.176 mill.


$ 1,236.802 mill.

Employees Shares Outstanding P/E

15,950


83 mill.


45.94

Revenue Growth Income Growth

MRQ Y/Y 4.89 %


MRQ Y/Y 144.76 %



NTRA

$105.51

$15.1800 16.81%
Last 90 Days


NTRA

$105.51

$15.1800 16.81%



Natera Inc

Natera Inc stock increased 16.81% during the previous 90 days.


Natera Inc operates as a genetic testing company that provides non-invasive screening and diagnostic tests for reproductive health, oncology, and organ transplantation. The company*s business model is built around offering cost-effective and accurate genetic testing solutions for both patients and healthcare providers. Natera primarily generates revenue by selling its proprietary tests and associated analysis services to customers, including hospitals, laboratories, and physicians.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 12,747.085 mill. $ 1,208.556 mill. $ -365.463 mill. 121 mill. - Y/Y 52.11 %
Market Cap. Revenues TTM Net Income TTM

$ 12,747.085 mill.


$ 1,208.556 mill.


$ -365.463 mill.

Employees Shares Outstanding P/E

2,800


121 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 52.11 %


MRQ Y/Y - %



MDXH

$2.8

$0.5000 21.74%
Last 90 Days


MDXH

$2.8

$0.5000 21.74%



Mdxhealth Sa

Mdxhealth Sa stock increased 21.74% during the previous 90 days.


MDxHealth SA is a biotech company that primarily focuses on developing and commercializing molecular diagnostic tests to assist healthcare professionals in making informed treatment decisions for cancer patients. Their business model revolves around providing accurate and actionable diagnostic information to improve patient outcomes and potentially reduce healthcare costs.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 72.699 mill. $ 70.193 mill. $ -43.100 mill. 26 mill. - Y/Y 89.43 %
Market Cap. Revenues TTM Net Income TTM

$ 72.699 mill.


$ 70.193 mill.


$ -43.100 mill.

Employees Shares Outstanding P/E

-


26 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 89.43 %


MRQ Y/Y - %




 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com